首页> 外国专利> Consumer-oriented biometrics data management and analysis system; for innovative electronic global access to health management tools all from the comfort amp; privacy of home and personalized analysis, predictive insights, amp; predictive blood glucose response

Consumer-oriented biometrics data management and analysis system; for innovative electronic global access to health management tools all from the comfort amp; privacy of home and personalized analysis, predictive insights, amp; predictive blood glucose response

机译:面向消费者的生物识别数据管理和分析系统;通过创新的电子方式全球访问健康管理工具,无论是在家中的舒适度和私密性还是个性化分析,预测见解和预测血糖反应

摘要

#$%^&*AU2020200693A120200220.pdf#####CONSUMER-ORIENTED BIOMETRICS DATA MANAGEMENT AND ANALYSIS SYSTEM; FOR INNOVATIVE ELECTRONIC GLOBAL ACCESS TO HEALTH MANAGEMENT TOOLS ALL FROM THE COMFORT & PRIVACY OF HOME AND PERSONALIZED ANALYSIS, PREDICTIVE INSIGHTS, & PREDICTIVE BLOOD GLUCOSE RESPONSE ABSTRACT An embodiment may involve receiving a set of information including data points for healthrelated data for a user. The embodiment may also involve performing (902), by an analytics engine (106), tests between (i) a series of one or more blood sugar levels (600) from the user measured at points in time, and (ii) data representing each of a normal blood sugar response (602), a pre-diabetic blood sugar response (604), and a diabetic blood sugar response (606). The embodiment may also involve based on the tests, making (904) a conclusion, by the analytics engine, that the series of one or more blood sugar levels from the user indicates the normal blood sugar response, the pre-diabetic blood sugar response, or the diabetic blood sugar response. The embodiment may also involve adding (906) an indication of the conclusion to a comprehensive health profile for the user.
机译:#$%^&* AU2020200693A120200220.pdf #####面向消费者的生物数据管理和分析系统;用于创新性电子全球健康管理工具全部来自家庭和个人的舒适和私密性个性化分析,预测见解和预测血液葡萄糖反应抽象一个实施例可以涉及接收包括用于健康的数据点的一组信息。用户的相关数据。该实施例还可以涉及由分析引擎执行(902)(106),在(i)来自使用者的一系列一个或多个血糖水平(600)之间进行的测试时间点;以及(ii)代表正常血糖反应(602),糖尿病前期血糖反应(604)和糖尿病血糖反应(606)。该实施例也可以根据测试,由分析引擎做出(904)的结论:使用者的血糖水平或以上表示正常的血糖反应,即糖尿病前期血糖反应或糖尿病血糖反应。该实施例还可能涉及将结论的指示添加(906)给用户的全面健康状况。

著录项

  • 公开/公告号AU2020200693A1

    专利类型

  • 公开/公告日2020-02-20

    原文格式PDF

  • 申请/专利权人 PRODUCTVISIONARIES LLC;

    申请/专利号AU20200200693

  • 发明设计人 MOLONEY-EGNATIOS KATE;

    申请日2020-01-30

  • 分类号G06Q50/22;

  • 国家 AU

  • 入库时间 2022-08-21 11:11:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号